Real Estate

Amirah Developments: 2025 Insights on Discipline and Trust in Real Estate

Amirah Developments Reflects on 2025 as a Year of Discipline, Trust, and Sustainable Growth

Strategic launches, steady sales progress, and strengthened partnerships position the developer for long-term expansion in Dubai’s evolving real estate market

Date: March 25, 2026; Dubai, UAE

As Dubai’s real estate sector continues to evolve into a more mature and end-user-driven market, Amirah Developments is reflecting on 2025 as a defining year that reinforced the company’s core philosophy of disciplined growth, transparent communication, and long-term value creation.

Over the past year, Dubai’s property market recorded remarkable activity, with total real estate transactions surpassing Dh893 billion, according to the Dubai Land Department. While these numbers highlight the scale of the market’s growth, they also reveal a deeper shift in buyer behaviour. Investors and homeowners alike are becoming increasingly selective, prioritising credibility, thoughtful design, and developers with a clear track record of delivery.

Continue reading Amirah Developments: 2025 Insights on Discipline and Trust in Real Estate →
Featured, Health Care

Orforglipron vs. Semaglutide: A New Era in Diabetes Treatment

Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

  • For the primary endpoint, orforglipron 36 mg lowered A1C by 2.2% vs. 1.4% with oral semaglutide 14 mg in ACHIEVE-3
  • In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (9.2%) compared to 11.0 lbs (5.3%) with oral semaglutide 14 mg, representing a 73.6% greater relative weight loss
  • Lilly has submitted orforglipron to regulators in over 40 countries, with potential U.S. action for obesity in Q2 2026

INDIANAPOLIS, March 24, 2026 — Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-3, the first head-to-head Phase 3 trial evaluating the safety and efficacy of orforglipron, a small molecule oral GLP-1 without food or water restrictions, compared with oral semaglutide in adults with type 2 diabetes inadequately controlled with metformin. The 52-week trial enrolled 1,698 participants across four treatment arms: orforglipron 12 mg and 36 mg, and oral semaglutide 7 mg and 14 mg. In ACHIEVE-3, orforglipron outperformed oral semaglutide across the primary and all key secondary endpoints, delivering significantly greater improvements in A1C and weight.1,2 The results were published today in The Lancet.

Continue reading Orforglipron vs. Semaglutide: A New Era in Diabetes Treatment →
Technologies

HUAWEI Mate 80 Pro: The Return of a Flagship Powerhouse

UAE, March 24, 2026 – The Mate series once represented the pinnacle of smartphone innovation. Now, the series returns to the global stage after a brief hiatus. Building on the Mate series’ strong tradition of pioneering technology, the Mate 80 Pro sets new standards in imaging authenticity, durability, performance, and intelligence. At a time when innovation among standard slab smartphones appears to have stalled, the Mate 80 Pro emerges as a serious contender for the best flagship smartphone of the year.

Continue reading HUAWEI Mate 80 Pro: The Return of a Flagship Powerhouse →
Technologies

Vault22 Launches AI-Driven Wealth Platform in UAE

The unified platform integrates budgeting, investing, and Shariah-compliant solutions

Dubai, UAE, March 2026: Fintech platform Vault22 has launched in the United Arab Emirates, introducing an AI-powered wealth platform designed to help individuals budget, save, and invest more effectively through a single digital application.

At its core, Vault22 is designed to simplify how people manage money. Instead of juggling multiple banking apps, spreadsheets and investment platforms, users can see their bank accounts, investments, liabilities and financial goals in one intelligent dashboard, helping them better understand their financial position and make clearer long-term decisions.

Continue reading Vault22 Launches AI-Driven Wealth Platform in UAE →
Technologies

Yango Tech Unveils AI Agents to Transform UAE Workforce

Yango Tech launches Industrial AI Agents to accelerate UAE’s digital workforce agenda

Dubai, UAE, 24 March 2026: Yango Tech, B2B technology solutions provider by Yango Group, launches a new business practice focused on developing and deploying autonomous industrial AI agents. These AI agents are designed to execute real operational tasks across customer service, analytics, compliance, and decision-making, serving industries such as fintech, medtech, e-commerce, logistics, smart cities, and the public sector.

Yango Tech offers both ready-to-deploy solutions and a customizable platform for building AI agents tailored to the specific needs of each business. This new business direction addresses the rapidly growing demand across the Middle East for scalable AI systems that deliver measurable business impact, as the region accelerates toward a projected $320 billion AI economy by 2030.

Continue reading Yango Tech Unveils AI Agents to Transform UAE Workforce →

Interesting News Blog